The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Merck & Co Inc

NYSE: MRK
Last

(U.S.) $63.88

Today's change+0.13 +0.20%
Updated October 20 4:00 PM EDT. Delayed by at least 15 minutes.
 

Merck & Co Inc

NYSE: MRK
Last

(U.S.) $63.88

Today's change+0.13 +0.20%
Updated October 20 4:00 PM EDT. Delayed by at least 15 minutes.

Merck & Co Inc crosses above 125-day moving average

Merck & Co Inc closed up Friday by (U.S.)$0.13 or 0.20% to (U.S.)$63.88 and crossing above its 125-day moving average. Over the last five days, shares have gained 0.77% and are currently 4.37% off of the 52-week high. Shares have underperformed the S&P 500 by 17.10% during the last year.

Key company metrics

  • Open(U.S.) $63.85
  • Previous close(U.S.) $63.75
  • High(U.S.) $63.99
  • Low(U.S.) $63.57
  • Bid / Ask(U.S.) $63.84 / (U.S.) $64.00
  • YTD % change+8.51%
  • Volume10,237,421
  • Average volume (10-day)7,389,812
  • Average volume (1-month)7,871,651
  • Average volume (3-month)8,016,816
  • 52-week range(U.S.) $58.29 to (U.S.) $66.80
  • Beta0.83
  • Trailing P/E34.79×
  • P/E 1 year forward16.47×
  • Forward PEG2.65×
  • Indicated annual dividend(U.S.) $1.88
  • Dividend yield2.94%
  • Trailing EPS(U.S.) $1.84
Updated October 20 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.25%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue9,9309,43410,11510,536
Total other revenue--------
Total revenue9,9309,43410,11510,536
Gross profit7,7097,3317,6157,935
Total cost of revenue2,2212,1032,5002,601
Total operating expense7,4337,37311,4647,625
Selling / general / administrative2,4362,4102,5642,356
Research & development1,6451,7711,2651,645
Depreciation / amortization779773800772
Interest expense (income), net operating--------
Unusual expense (income)3523164,335251
Other operating expenses, total--------
Operating income2,4972,061-1,3492,911
Interest income (expense), net non-operating-193-182-180-170
Gain (loss) on sale of assets--------
Other--------
Income before tax2,4392,003-1,3562,887
Income after tax1,9511,556-5872,188
Income tax, total488447-769699
Net income1,9461,551-5952,184
Total adjustments to net income--------
Net income before extra. items1,9461,551-5952,184
Minority interest-5-5-8-4
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,9461,551-5952,184
Inc. avail. to common incl. extra. items1,9461,551-5952,184
Diluted net income1,9461,551-5952,184
Dilution adjustment--------
Diluted weighted average shares2,7522,7662,7572,786
Diluted EPS excluding extraordinary itemsvalue per share0.710.56-0.220.78
Dividends per sharevalue per share0.470.470.460.46
Diluted normalized EPSvalue per share1.331.162.421.42